ICIs have achieved favorable efficacy for Merkel cell carcinoma, a type of NEN originating from the skin; and this tumor, with a high level infiltration of CD8+ T cells, significantly responds to ICIs, and more improved clinical outcomes have been observed [38,39]. The gene discussed is CD8A; the disease is Merkel cell skin cancer.